Stock Events

Stock Events

Shin Nippon Biomedical Laboratories 

¥1,331
12
-¥4-0.3% 03:35 Today

Statistics

Day High
1,338
Day Low
1,312
52W High
2,005
52W Low
1,067
Volume
56,900
Avg. Volume
209,933
Mkt Cap
55.41B
P/E Ratio
16.68
Dividend Yield
2.17%
Dividend
28.93

Upcoming

Dividends

2.17%Dividend Yield
Jun 26
¥30
Nov 25
¥20
Jun 25
¥30
Nov 24
¥20
Jun 24
¥30
10Y Growth
N/A
5Y Growth
29.15%
3Y Growth
-6.16%
1Y Growth
-10.08%

Earnings

5NovExpected
Q1 2025
Q2 2025
Q3 2025
Q4 2025
Q1 2026
Q2 2026
Next
6.4
22.47
38.54
54.61
Expected EPS
N/A
Actual EPS
N/A

Financials

15.19%Profit Margin
Profitable
2019
2020
2021
2022
2023
2024
32.41BRevenue
4.92BNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow 2395.TSE. It's not an investment recommendation.
Takeda Pharmaceutical
4
4502.TSE
Mitsubishi UFJ Financial Group
3
8306.TSE
KDDI
3
9433.TSE
Nippon Yusen Kabushiki Kaisha
3
9101.TSE

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Charles River Laboratories International
CRL
Mkt Cap13.77B
Charles River Laboratories provides a similar range of preclinical and clinical laboratory services for the pharmaceutical, medical device, and biotechnology industries, directly competing with SBLOF's offerings.
IQVIA
IQV
Mkt Cap44.07B
IQVIA offers extensive clinical research services, including laboratory services, making it a competitor in the pharmaceutical and healthcare research space.
Icon Energy
ICON
Mkt Cap3.31M
ICON plc provides clinical research services to the pharmaceutical, biotechnology, and medical device industries, competing in the same space as SBLOF.
Wuxi AppTec.
WUXAY
Mkt Cap60.27B
WuXi AppTec provides a broad range of R&D and manufacturing services in the pharmaceutical, biotechnology, and medical device industries, competing with SBLOF in the area of preclinical research services.

About

Shin Nippon Biomedical Laboratories, Ltd., a contract research organization, provides drug discovery and development services in Japan and internationally. It offers pre-clinical laboratory services, such as good laboratory practice inspections; general and specific toxicity studies; pathological examinations; PK/PD of biopharmaceuticals, immunotoxicity tests, and antibody production; reproductive and developmental toxicity studies; pharmacology and pharmacological efficacy studies; and imaging services. The company also engages in the establishment and validation of analytical methods, analysis of biological samples, and calculation of pharmacokinetic parameters; and provides absorption, distribution, metabolism, and excretion studies using radioisotope-labeled compounds. In addition, it provides site management organization services for clinical trials; clinical contract research organization services; and translational research services, including research and development of nasal delivery systems, nucleic acid adjuvants, and regenerative medicines. The company was founded in 1957 and is headquartered in Tokyo, Japan.
Show more...
CEO
Dr. Ryoichi Nagata F.F.P.M., M.D., Ph.D.
Employees
1050
Country
Japan
ISIN
JP3379950003
WKN
000A0BMJN

Listings

STU
DE
YB3.STU
MU
DE
YB3.MU
TSE
JP
2395.TSE
F
DE
YB3.F

0 Comments

Share your thoughts

FAQ

What is Shin Nippon Biomedical Laboratories stock price today?▼
The current price of 2395.TSE is ¥1,331 JPY — it has decreased by -0.3% in the past 24 hours. Watch Shin Nippon Biomedical Laboratories stock price performance more closely on the chart.
What is Shin Nippon Biomedical Laboratories stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on Tokyo Stock Exchange exchange Shin Nippon Biomedical Laboratories stocks are traded under the ticker 2395.TSE.
Is Shin Nippon Biomedical Laboratories stock price growing?▼
2395.TSE stock has fallen by -4.6% compared to the previous week, the month change is a -9.8% fall, over the last year Shin Nippon Biomedical Laboratories has showed a -23.84% decrease.
What is Shin Nippon Biomedical Laboratories market cap?▼
Today Shin Nippon Biomedical Laboratories has the market capitalization of 55.41B
When is the next Shin Nippon Biomedical Laboratories earnings date?▼
Shin Nippon Biomedical Laboratories is going to release the next earnings report on November 05, 2026.
What were Shin Nippon Biomedical Laboratories earnings last quarter?▼
2395.TSE earnings for the last quarter are 24.75 JPY per share, whereas the estimation was N/A JPY resulting in a N/A surprise. The estimated earnings for the next quarter are N/A JPY per share.
What is Shin Nippon Biomedical Laboratories revenue for the last year?▼
Shin Nippon Biomedical Laboratories revenue for the last year amounts to 32.41B JPY.
What is Shin Nippon Biomedical Laboratories net income for the last year?▼
2395.TSE net income for the last year is 4.92B JPY.
Does Shin Nippon Biomedical Laboratories pay dividends?▼
Yes, 2395.TSE dividends are paid semi-annual. The last dividend per share was 30 JPY. As of today, Dividend Yield (FWD)% is 2.17%.
How many employees does Shin Nippon Biomedical Laboratories have?▼
As of September 08, 2026, the company has 1,050 employees.
In which sector is Shin Nippon Biomedical Laboratories located?▼
Shin Nippon Biomedical Laboratories operates in the Health & Wellness sector.
When did Shin Nippon Biomedical Laboratories complete a stock split?▼
Shin Nippon Biomedical Laboratories has not had any recent stock splits.
Where is Shin Nippon Biomedical Laboratories headquartered?▼
Shin Nippon Biomedical Laboratories is headquartered in Tokyo, Japan.